A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol.
Endocrinol Metab (Seoul)
; 36(3): 574-581, 2021 06.
Article
en En
| MEDLINE
| ID: mdl-34034365
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Calidad de Vida
/
Neoplasias de la Tiroides
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Endocrinol Metab (Seoul)
Año:
2021
Tipo del documento:
Article